Provided herein are compounds of the formula (IV) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful as MITF inhibitors, MITF pathway inhibitors and for the treatment of cancer.
申请公布号
WO2014201016(A3)
申请公布日期
2015.02.05
申请号
WO2014US41730
申请日期
2014.06.10
申请人
THE GENERAL HOSPITAL CORPORATION;THE BROAD INSTITUTE;UNIVERSITY OF KANSAS
发明人
FALOON, PATRICK;WEINER, WARREN S.;SMITH, ROBERT A.;SCHOENEN, FRANK JOHN;FISHER, DAVID E.;HAQ, RIZWAN